You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Investment bank BTIG has initiated coverage of CareDx's stock with a Buy rating and a price target of $40.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.